Skip to main content
    Fact-checked by the Peptide Authority Editorial Board · Last reviewed:
    Safety Centre

    Illegal peptide seller tactics

    Unlicensed peptide and GLP-1 sellers targeting UK consumers use a recurring playbook. Pattern recognition is the most useful single defence — once you've seen the moves twice, you spot them in two seconds. This guide breaks the playbook down.

    Looking legitimate

    Stolen or repurposed branding

    Cloned logos, copied product photos from official manufacturer sites, fake ‘CE’ or ‘GMP’ marks, claimed accreditations from non-existent bodies. A website that looks polished isn’t evidence of legitimacy — it’s a 200-pound design investment.

    Borrowed trust signals

    ‘As featured in [publication]’ where the publication never covered the brand. ‘Trusted by 50,000 customers’ with no verifiable source. ‘Doctor recommended’ with no named doctor. Trustpilot pages with bot reviews. UK address on a contact page that belongs to a virtual mail forwarder.

    Fake regulatory references

    ‘MHRA-compliant’ (not a defined status). ‘FDA cleared’ for a UK consumer (irrelevant to UK supply). ‘Lab-tested with certificates of analysis on request’ where the CoA is fabricated, copied from a different batch, or for a different product entirely.

    Building trust quickly

    Tiny first purchases

    Some sellers ship a real, low-quantity first order to a customer to build trust before substituting counterfeit or inactive product for subsequent orders. The pattern lets them accumulate positive reviews while reserving the dangerous supply for repeat buyers.

    Free samples

    ‘Free trial’ offers for unlicensed-medicine supply are not loss leaders — they’re the entry into a continuing relationship that rapidly becomes paid.

    Affiliated influencers

    Recruiting influencers to post before-and-afters with discount codes. The influencer didn’t necessarily use the product; some discount codes are simply commission tags.

    Evading reporting and enforcement

    Domain hopping

    A seller appears under one domain, builds traffic, gets reported / takedown notice, and reappears under a near-identical domain. The same business migrates across 4–6 domains per year. Look for word-for-word identical site copy at different URLs.

    Disposable contact channels

    Telegram channels that delete and recreate, Snapchat handles that change, burner WhatsApp numbers, generic email addresses (Gmail, ProtonMail). Real businesses have continuity; illegal sellers manufacture impermanence.

    Crypto payment

    Bitcoin, Monero, USDT — payment routes that bypass card chargeback and bank reversal. Sometimes accompanied by ‘we accept regulated payment too’ as a fallback to look legitimate, with crypto offered at a ‘discount’.

    Off-platform handoffs

    Initial contact on Instagram or TikTok where the platform enforces against drug sales; conversation moved to a disappearing-message app for the actual transaction. The platform with the audience isn’t the platform with the sale.

    Evading clinical accountability

    Tickbox ‘assessment’ forms

    Forms designed to be passed regardless of answers. Sometimes the form has hidden logic that ‘upgrades’ a no to a yes if you re-read it. Forms collected and approved en bloc by a doctor signing off lists rather than assessing patients.

    Foreign-prescriber loophole

    ‘Our doctor is based in [country]’ used to obscure whether UK prescriber accountability applies. Cross-border POM supply into the UK isn’t exempt from UK rules just because the prescriber sits abroad.

    Anonymous-doctor framing

    ‘A doctor will contact you for prescription approval’ where the doctor is never named and never identifiable. This framing is incompatible with regulated practice.

    Evading product accountability

    Repackaged genuine product

    Genuine pens removed from original packaging and rebottled for resale. The medicine may be real but you lose the PIL, the tamper-evident seal, batch traceability, and the cold-chain assurance.

    Counterfeit pen with real-looking branding

    Falsified pens that closely mimic the licensed product. Identifiable on close inspection (printing quality, PIL absent or wrong language, batch mismatches) but easy to miss for a first-time buyer.

    Insulin in a GLP-1 pen

    Documented counterfeit pattern. The seller saves cost by filling with a cheaper substance; the user takes what they think is semaglutide and gets an acute hypoglycaemic episode.

    How to report patterns you spot

    • MHRA — report a problem with a medicine. Include URLs, screenshots, and pattern observations.
    • Platform reporting on Instagram, TikTok, Facebook etc. for the seller account itself.
    • Action Fraud if you’ve lost money or received fake product.
    • ASA for advertising and influencer breaches — see peptide advertising rules.

    Sources & further reading

    Last reviewed:

    Next review due:

    Spotted an error or something out of date? Send a correction.

    Related